Intravitreal bevacizumab versus bevacizumab and 1 mg triamcinolone acetonide in eyes with bilateral diabetic macular edema
Özet
AIM: To compare of intravitreal bevacizumab and intravitreal bevacizumab and triamcinolone acetonide in eyes with bilateral diabetic macular edema. METHODS: In this retrospective comparative-randomized study, 42 eyes of 21 diabetic patients with bilateral macular edema were evaluated. In one eye intravitreal injection of 1.25 mg bevacizumab (IVB group) was performed and in the fellow eye intravitreal injection of combined 1.25 mg bevacizumab and 1 mg triamcinolone acetonide (IVTA-IVB group) was performed. Main outcomes were the central macular thickness (CMT) measured with optical coherence tomography (OCT), ETDRS visual acuity (VA) and intraocular pressure (IOP). RESULTS: Mean follow-up time was 4.7±1.5mo. In the IVB and IVTA-IVB groups, mean CMT was 494.7±114.4 ?m and 546.8±165.6 ?m before injections; 430.4±133.2 ?m and 363.7±105.3 ?m in first month; 484.8±167.4 ?m and 407.3±108.7 ?m in 3rd month; 550.4±191.5 ?m and 516.8±158 ?m after 6mo respectively. Differences were significant in first and 3rd months (P<0.05). In the IVB and IVTA-IVB groups, mean ETDRS VA score was 57.1±13.5 and 48.9±13.9 before injections; 62.2±14 and 58.8±12.1 in first month; 59±13.7 and 59.3±13.6 in 3rd month; 55.6±14.9 and 55.5±8.7 after 6mo respectively. Differences were significant in first and 3rd and 6mo (P<0.05). There was no IOP difference. IVTA-IVB group gains best VA in 3rd month after the first injection and maintains it for 6mo whereas IVB group gains best VA at first month and can be able to maintain for 3mo. CONCLUSION: Injection of 1 mg IVTA-IVB seems to be better than IVB alone in improving VA for 6mo without any steroid dependent complications. Copyright 2019 by the IJO Press.
Cilt
19Sayı
1Bağlantı
https://doi.org/10.3980/j.issn.1672-5123.2019.1.01https://hdl.handle.net/20.500.11776/5728
Koleksiyonlar
İlgili Öğeler
Başlık, yazar, küratör ve konuya göre gösterilen ilgili öğeler.
-
Evaluation of Calciferol, Cobalamin, and Stromelysin-1 in Patients with Diabetic Peripheral Neuropathy due to Type-2 Diabetes Mellitus
Bilir, Bülent; Yılmaz, İbrahim; Karaarslan, Numan; Bilir, B.E.; Kaplan, Nuray; Özbek, Hanefi (College of Physicians and Surgeons Pakistan, 2022)Objective: To evaluate the relationship between calciferol (vitamin D), cobalamin (vitamin-B12), and Stromelysin-1 (MMP-3) circulating levels in patients with diabetic peripheral neuropathy (DPN), patients with DM type 2 ... -
MAPK immunoreactivity in streptozotocin-induced diabetic rat testis
Dönmez, Yeliz Bozdemir; Kizilay, G.; Topcu-Tarladacalisir, Y. (Sociedade Brasileira para o Desenvolvimento de Pesquisa em Cirurgia, 2014)PURPOSE: To evaluate the alterations of two mitogen-activated protein kinases (MAPK)s, extracellular signal regulated kinase (ERK) and c-Jun NH2 terminal kinase (JNK), in the testes of male rats with experimental ... -
Firmicutes/Bacteroidetes Ratio in the Gut Microbiota and IL-1?, IL-6, IL-8, TLR2, TLR4, TLR5 Gene Expressions in Type 2 Diabetes
Bahar-Tokman, H.; Demirci, Mehmet; Keskin, Fatma E.; Çağatay, P.; Taner, Z.; Öztürk-Bakar, Y.; Kiraz, Nuri; Kocazeybek, B.S. (Verlag Klinisches Labor GmbH, 2022)Background: The aim of this study was to determine the Firmicutes/Bacteroidetes ratio in the gut microbiota and IL-1?, IL-6, IL-8, TLR2, TLR4 and TLR5 gene expression levels in the blood of adult type 2 diabetes (T2D) ...